DE218478C - - Google Patents
Info
- Publication number
- DE218478C DE218478C DENDAT218478D DE218478DA DE218478C DE 218478 C DE218478 C DE 218478C DE NDAT218478 D DENDAT218478 D DE NDAT218478D DE 218478D A DE218478D A DE 218478DA DE 218478 C DE218478 C DE 218478C
- Authority
- DE
- Germany
- Prior art keywords
- acid
- parts
- benzene
- water
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002253 acid Substances 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 15
- 239000000155 melt Substances 0.000 claims description 8
- 150000007513 acids Chemical class 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- VEQOALNAAJBPNY-UHFFFAOYSA-N Phenazone Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 229960005222 phenazone Drugs 0.000 description 10
- 229940091110 Antipyrine Drugs 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- -1 Dimethylglycolic acid phenyldimethylpyrazolone Chemical compound 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 6
- MBIQENSCDNJOIY-UHFFFAOYSA-N 2-hydroxy-2-methylbutyric acid Chemical compound CCC(C)(O)C(O)=O MBIQENSCDNJOIY-UHFFFAOYSA-N 0.000 description 4
- RXXLWJKVDZLVHR-UHFFFAOYSA-N 4-benzyl-5-methylpyrazol-3-one Chemical compound O=C1N=NC(C)=C1CC1=CC=CC=C1 RXXLWJKVDZLVHR-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000005712 crystallization Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 2
- 208000008085 Migraine Disorders Diseases 0.000 description 2
- 230000001754 anti-pyretic Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- WQAQKERCWPUIMH-UHFFFAOYSA-N 1,5-dimethyl-2-phenylpyrazol-3-one;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.CN1C(C)=CC(=O)N1C1=CC=CC=C1 WQAQKERCWPUIMH-UHFFFAOYSA-N 0.000 description 1
- LXVSANCQXSSLPA-UHFFFAOYSA-N 2-Ethyl-2-Hydroxybutyric acid Chemical compound CCC(O)(CC)C(O)=O LXVSANCQXSSLPA-UHFFFAOYSA-N 0.000 description 1
- JRQZJRDOZAJRTN-UHFFFAOYSA-N 2-hydroxy-2,3-dimethylbutanoic acid Chemical compound CC(C)C(C)(O)C(O)=O JRQZJRDOZAJRTN-UHFFFAOYSA-N 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000003467 Cheek Anatomy 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K Iron(III) chloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N Mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N Methadone Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N Methyl isopropyl ketone Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 1
- 206010027599 Migraine Diseases 0.000 description 1
- 208000004296 Neuralgia Diseases 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N Phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- 230000000254 damaging Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
DE218478C true DE218478C (xx) |
Family
ID=479697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT218478D Active DE218478C (xx) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE218478C (xx) |
-
0
- DE DENDAT218478D patent/DE218478C/de active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69311130T2 (de) | Arylpropionsäurederivat, verfahren zu seiner herstellung und seine verwendung als analgetikum | |
DE218478C (xx) | ||
DE2724183C2 (de) | 2-(4-Isobutylphenyl)propionsäure-p-hydroxyphenylharnstoffester und Verfahren zu seiner Herstellung | |
DE69705405T2 (de) | Neue formen der organischen salze des n'n-diacetylcystins | |
DE169819C (xx) | ||
DE2008332C3 (de) | 2-Methyl-S-methoxy-3-indolylacetohydroxamsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE234631C (xx) | ||
DE148977C (xx) | ||
DE125988C (xx) | ||
DE68916912T2 (de) | Zinncysteat, dessen Herstellung und dessen pharmazeutische und kosmetische Verwendungen. | |
DE854952C (de) | Verfahren zur Herstellung von komplexen Aureomycin-Verbindungen | |
DE829166C (de) | Verfahren zur Herstellung von N-(p-Arsenosobenzyl)-glycinamid und dessen Salzen | |
DE153767C (xx) | ||
DE613125C (de) | Verfahren zur Darstellung von wasserloeslichen Verbindungen der Oxydiphenylaether und deren Substitutionsprodukten | |
DE287661C (xx) | ||
DE303450C (xx) | ||
DE343323C (xx) | ||
DE1443297C3 (de) | 20.07.61 USA 125373 5-Amino-2,4,6-trijodisophthalamidsäurederivate Verfahren zu ihrer Herstellung und diese enthaltende Röntgenkontrastmittel Mallinckrodt Chemical Works, St. Louis, Mo. (V.St.A.) | |
DE1795003C3 (de) | 4H-13-Benzoxazin-2-on-3-acetohydroxamsäure, Verfahren zu deren Herstellung und Arzneimittel | |
DE859154C (de) | Verfahren zur Herstellung von Schiff'schen Basen der p-Aminosalicylsaeure | |
DE504681C (de) | Verfahren zur Herstellung pharmazeutischer Praeparate | |
DE1961527A1 (de) | Kristalline Form von Citronensaeureanhydrid | |
DE827493C (de) | Verfahren zur Herstellung von Produkten der Thiosemicarbazonreihe | |
DE633981C (de) | Verfahren zur Herstellung wohldefinierter kristalliner Nitrate des Phenylquecksilberhydroxyds | |
DE541147C (de) | Verfahren zur Herstellung wasserloeslicher Salze der Phenylchinolincarbonsaeure und ihrer Derivate |